BioNTech challenges AstraZeneca with breast cancer precision drug trial – ET HealthWorld | Pharma
Frankfurt: BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against…
Fast News Hear
Frankfurt: BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against…
Zurich: Sandoz on Monday announced a deal to buy Cimerli, a biosimilar drug to treat vision impairment and loss, from…
In the ever-evolving landscape of pharmaceuticals, where precision, safety, and trust are non-negotiable, blockchain technology emerges as the beacon of…
New Delhi: The Organisation of Pharmaceutical Producers of India (OPPI), which represents prominent multinational pharma companies, has urged the drug…
New Delhi: The U.S. Food and Drug Administration (FDA) granted full approval to Swedish drugmaker Calliditas Therapeutics‘ drug to treat…
New Delhi: Roche agreed to take over obesity drug developer Carmot Therapeutics for $2.7 billion, joining a list global contestants…
The government is likely to soon come up with a mechanism for providing treatment support to patients suffering from rare…
Zurich: Roche on Monday said it will buy Telavant, a developer of a new treatment for inflammatory bowel diseases, for…
Bengaluru: Royalty Pharma said on Thursday it has purchased additional royalties on Roche and PTC Therapeutics’ oral spinal muscular atrophy…
FILE PHOTO-The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann/File…